# Ondansetron

NDC: 80425-0227
Generic name: Ondansetron
Labeler / Manufacturer: Advanced Rx Pharmacy of Tennessee, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, ORALLY DISINTEGRATING
Routes: ORAL
Marketing started: 20230111

FDA application: ANDA078152

## Active ingredients

- ONDANSETRON: 8 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"80425-0227"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=80425-0227
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f1a0cd50-aa4f-55bc-e053-2995a90a2d3a